RxDoctor Payments Data

Michael Scherl, MD

Otolaryngology · Westwood, NJNPI 1801894183

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.8% of the total across 188 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,429 and has fallen 77.4% since, to $323 in 2025. Among otolaryngology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,264in general payments, 2019–2025

Across 188 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$884
  • Regeneron Healthcare Solutions, Inc.$850
  • Sanofi$736
  • GSK$645
  • Optinose US, Inc.$432
  • Aerin Medical Inc.$135
  • plus $581 from 16 others

What the payments were for

  • Food & beverage$4,21199%
  • Education$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,264 in reported general payments places this provider in the 90th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$304,043
Medicare patients
1,064
Services billed
2,810

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab51$214,519
Dupixent SyringeDupilumab23$85,067
Ipratropium Bromide304$7,189
Fluocinolone Acetonide Oil99$3,874
Azelastine Hcl132$3,261
Azelastine-FluticasoneAzelastine/Fluticasone20$2,814
Ofloxacin63$1,366
Olopatadine Hcl19$1,217
Clobetasol EmollientClobetasol Propionate/Emoll30$1,179
Pilocarpine Hcl18$1,056
Mometasone Furoate26$837
Montelukast Sodium119$824
Acetazolamide13$441
Methylprednisolone44$323
Nystatin18$313

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Westwood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →